| Name | Title | Contact Details |
|---|---|---|
Travis Moyer |
Vice President of Legal | Profile |
Solx is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Covalent Medical Inc is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Healthline Med, Inc is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Medbox, Inc. develops, sells, and services automated, biometrically controlled dispensing and storage systems for medicine and merchandise applications. Its products comprise Medbox medicine storage machines; safe access storage lockers; Medbox lockbox Rx storage/retrieval systems; Medbox OTC machines; and Medbox Sample-Safe, a wall-mounted unit for use in doctor’s offices. Medbox, Inc. provides its patented systems, software, and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities and medical groups worldwide. The company was formerly known as MindfulEye, Inc. and changed its name to Medbox, Inc. in August 2011. Medbox, Inc. is headquartered in West Hollywood, California.
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.